HIGH RATES OF NON-RELAPSE MORTALITY AND GRAFT-VERSUS-HOST DISEASE IN PATIENT UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION (ASCT) FOLLOWING NON-MYELOABLATIVE (NMA) CONDITIONING WITH TLI/ATG

被引：0
|
作者：
Kanate, A. S. [1 ]
Chaudhary, L. [1 ]
Cumpston, A. [1 ]
Leadmon, S. [1 ]
Bunner, P. [1 ]
Bulian, D. [1 ]
Gibson, L. [1 ]
Tse, W. [1 ]
Abraham, J. [1 ]
Remick, S. [1 ]
Craig, M. [1 ]
Hamadani, M. [1 ]
机构：
[1] W Virginia Univ, Morgantown, WV 26506 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2011年 / 17卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2010.12.476
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
440
引用
收藏
页码：S313 / S313
页数：1
相关论文
共 50 条
  • [21] Allogeneic blood stem cell transplantation following non-myeloablative conditioning for hypereosinophilic syndrome
    E Juvonen
    L Volin
    A Koponen
    T Ruutu
    Bone Marrow Transplantation, 2002, 29 : 457 - 458
  • [22] Pre-engraftment serum C-reactive protein value may predict acute graft-versus-host disease and non-relapse mortality in patients undergoing allogeneic myeloablative haematopoietic stem cell transplantation
    Fuji, S.
    Kim, S.
    Mori, S.
    Fukuda, T.
    Tanosaki, R.
    Heike, Y.
    Tobinai, K.
    Takaue, Y.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S108 - S109
  • [23] The early assessment of the systemic inflammatory response syndrome score is able to predict acute graft-versus-host disease and non-relapse mortality in patients undergoing an allogeneic stem cell transplantation
    De Philippis, C.
    Spina, F.
    Farina, L.
    Roncari, L.
    Soldarini, M.
    Dodero, A.
    Montefusco, V.
    Perrone, G.
    Corradini, P.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S36 - S37
  • [24] Plasma-based protein biomarkers can predict the risk of acute graft-versus-host disease and non-relapse mortality in patients undergoing allogeneic hematopoietic stem cell transplantation
    Shin, Junghoon
    Dan, Kisoon
    Han, Dohyun
    Kim, Ji-Won
    Kim, Kyung Kon
    Koh, Youngil
    Shin, Dong-Yeop
    Hong, Junshik
    Yoon, Sung-Soo
    Park, Seonyang
    Song, Sang Hoon
    Kim, Inho
    BLOOD CELLS MOLECULES AND DISEASES, 2019, 74 : 5 - 12
  • [25] Allogeneic blood stem cell transplantation following non-myeloablative conditioning for hypereosinophilic syndrome
    Juvonen, E
    Volin, L
    Koponen, A
    Ruutu, T
    BONE MARROW TRANSPLANTATION, 2002, 29 (05) : 457 - 458
  • [26] Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection
    B J Byrne
    M Horwitz
    G D Long
    C Gasparetto
    K M Sullivan
    J Chute
    N J Chao
    D A Rizzieri
    Bone Marrow Transplantation, 2008, 41 : 39 - 43
  • [27] Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation
    Mielcarek, M
    Burroughs, L
    Leisenring, W
    Diaconescu, R
    Martin, PJ
    Sandmaier, BM
    Maloney, DG
    Maris, MB
    Chauncey, TR
    Shizuru, JA
    Blume, KG
    Hegenbart, U
    Niederwieser, D
    Forman, S
    Bruno, B
    Woolfrey, A
    Storb, R
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (03) : 381 - 391
  • [28] Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: A comparison of myeloablative and non-myeloablative conditioning regimens.
    Sala-Torra, Olga
    Martin, Paul J.
    Storer, Barry
    Sorror, Mohamed
    Storb, Rainer F.
    Sandmaier, Brenda M.
    Flowers, Mary E. D.
    BLOOD, 2006, 108 (11) : 227A - 227A
  • [29] Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection
    Byrne, B. J.
    Horwitz, M.
    Long, G. D.
    Gasparetto, C.
    Sullivan, K. M.
    Chute, J.
    Chao, N. J.
    Rizzieri, D. A.
    BONE MARROW TRANSPLANTATION, 2008, 41 (01) : 39 - 43
  • [30] Risk factors associated with the development of moderate to severe chronic graft-versus-host disease after non-myeloablative conditioning allogeneic stem cell transplantation in patients with AML or MDS
    Laurence M. C. Kok
    Laura Bungener
    Geertruida H. de Bock
    Anouschka Biswana
    Geertiena van der Wal
    Gustaaf W. van Imhoff
    Mar Bellido
    Human Cell, 2020, 33 : 243 - 251
12345